{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:07:43Z","timestamp":1764997663289,"version":"3.32.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,25]]},"DOI":"10.7759\/cureus.76374","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T16:27:26Z","timestamp":1735144046000},"source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the Role of Allopurinol in Mitigating Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Hassan","family":"Badreldin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhakar","family":"Mallya Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.04.068","article-title":"Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial","volume":"167","author":"Erol T","year":"2013","unstructured":"Erol T, Tekin A, Kat\u0131rc\u0131ba\u015f\u0131 MT, et al.. Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial. Int J Cardiol. 2013, 167:1396-9. 10.1016\/j.ijcard.2012.04.068","journal-title":"Int J Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.33963\/KP.a2022.0123","article-title":"Risk factors of contrast-induced nephropathy in patients with acute coronary syndrome","volume":"80","author":"Rakowski T","year":"2022","unstructured":"Rakowski T, Dziewierz A, W\u0119giel M, et al.. Risk factors of contrast-induced nephropathy in patients with acute coronary syndrome. Kardiol Pol. 2022, 80:760-4. 10.33963\/KP.a2022.0123","journal-title":"Kardiol Pol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5114\/amsad.2021.112226","article-title":"Protective effect of allopurinol in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"6","author":"Mansoor K","year":"2021","unstructured":"Mansoor K, Suliman M, Amro M, et al.. Protective effect of allopurinol in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Arch Med Sci Atheroscler Dis. 2021, 6:e196-202. 10.5114\/amsad.2021.112226","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00884-0","article-title":"Global epidemiology of acute coronary syndromes","volume":"20","author":"Timmis A","year":"2023","unstructured":"Timmis A, Kazakiewicz D, Townsend N, Huculeci R, Aboyans V, Vardas P. Global epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2023, 20:778-88. 10.1038\/s41569-023-00884-0","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.06.33","article-title":"Epidemiology of coronary heart disease and acute coronary syndrome","volume":"4","author":"Sanchis-Gomar F","year":"2016","unstructured":"Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016, 4:256. 10.21037\/atm.2016.06.33","journal-title":"Ann Transl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2007.03.007","article-title":"Epidemiology of myocardial infarction","volume":"91","author":"Roger VL","year":"2007","unstructured":"Roger VL. Epidemiology of myocardial infarction. Med Clin North Am. 2007, 91:537-52; ix. 10.1016\/j.mcna.2007.03.007","journal-title":"Med Clin North Am"},{"key":"ref7","article-title":"Percutaneous coronary intervention","author":"Ahmad M","year":"2024","unstructured":"Ahmad M, Mehta P, Reddivari AKR, et al.. Percutaneous coronary intervention. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124399","article-title":"Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry","volume":"10","author":"Numasawa Y","year":"2015","unstructured":"Numasawa Y, Kohsaka S, Miyata H, et al.. Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry. PLoS One. 2015, 10:e0124399. 10.1371\/journal.pone.0124399","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211005972","article-title":"Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis","volume":"49","author":"Wang J","year":"2021","unstructured":"Wang J, Zhang C, Liu Z, Bai Y. Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis. J Int Med Res. 2021, 49:3000605211005972. 10.1177\/03000605211005972","journal-title":"J Int Med Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14842","article-title":"Contrast-induced nephropathy: a review of mechanisms and risks","volume":"13","author":"Shams E","year":"2021","unstructured":"Shams E, Mayrovitz HN. Contrast-induced nephropathy: a review of mechanisms and risks. Cureus. 2021, 13:e14842. 10.7759\/cureus.14842","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S105124","article-title":"The potential use of biomarkers in predicting contrast-induced acute kidney injury","volume":"9","author":"Andreucci M","year":"2016","unstructured":"Andreucci M, Faga T, Riccio E, Sabbatini M, Pisani A, Michael A. The potential use of biomarkers in predicting contrast-induced acute kidney injury. Int J Nephrol Renovasc Dis. 2016, 9:205-21. 10.2147\/IJNRD.S105124","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200609000-00011","article-title":"Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery","volume":"105","author":"Wagener G","year":"2006","unstructured":"Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006, 105:485-91. 10.1097\/00000542-200609000-00011","journal-title":"Anesthesiology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2478\/v10039-009-0036-1","article-title":"NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine","volume":"54","author":"Bachorzewska-Gajewska H","year":"2009","unstructured":"Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine. Adv Med Sci. 2009, 54:221-4. 10.2478\/v10039-009-0036-1","journal-title":"Adv Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.06.009","article-title":"Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies","volume":"180","author":"Mamoulakis C","year":"2017","unstructured":"Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, et al.. Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies. Pharmacol Ther. 2017, 180:99-112. 10.1016\/j.pharmthera.2017.06.009","journal-title":"Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/123589","article-title":"Why is diabetes mellitus a risk factor for contrast-induced nephropathy?","volume":"2013","author":"Heyman SN","year":"2013","unstructured":"Heyman SN, Rosenberger C, Rosen S, Khamaisi M. Why is diabetes mellitus a risk factor for contrast-induced nephropathy?. Biomed Res Int. 2013, 2013:123589. 10.1155\/2013\/123589","journal-title":"Biomed Res Int"},{"key":"ref16","article-title":"ACR manual on contrast media: 2018 updates","volume":"91","author":"Kodzwa R","year":"2019","unstructured":"Kodzwa R. ACR manual on contrast media: 2018 updates. Radiol Technol. 2019, 91:97-100.","journal-title":"Radiol Technol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3292","article-title":"A review: Radiographic iodinated contrast media-induced thyroid dysfunction","volume":"100","author":"Lee SY","year":"2015","unstructured":"Lee SY, Rhee CM, Leung AM, Braverman LE, Brent GA, Pearce EN. A review: Radiographic iodinated contrast media-induced thyroid dysfunction. J Clin Endocrinol Metab. 2015, 100:376-83. 10.1210\/jc.2014-3292","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1051\/bmdcn\/2018080101","article-title":"The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM)","volume":"8","author":"Yang JS","year":"2018","unstructured":"Yang JS, Peng YR, Tsai SC, et al.. The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM). Biomedicine (Taipei). 2018, 8:1. 10.1051\/bmdcn\/2018080101","journal-title":"Biomedicine (Taipei)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mric.2017.06.003","article-title":"Current radiographic iodinated contrast agents","volume":"25","author":"Spampinato MV","year":"2017","unstructured":"Spampinato MV, Abid A, Matheus MG. Current radiographic iodinated contrast agents. Magn Reson Imaging Clin N Am. 2017, 25:697-704. 10.1016\/j.mric.2017.06.003","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl215","article-title":"Contrast-induced nephropathy--prevention and risk reduction","volume":"21","author":"Lameire NH","year":"2006","unstructured":"Lameire NH. Contrast-induced nephropathy--prevention and risk reduction. Nephrol Dial Transplant. 2006, 21:i11-23. 10.1093\/ndt\/gfl215","journal-title":"Nephrol Dial Transplant"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20598","article-title":"Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease","volume":"67","author":"Toprak O","year":"2006","unstructured":"Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv. 2006, 67:227-35. 10.1002\/ccd.20598","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2015.12.013","article-title":"Commentary on \u2018contrast-induced nephropathy and long-term renal decline after percutaneous transluminal angioplasty for symptomatic peripheral arterial disease.\u2019","volume":"51","author":"Rancic ZS","year":"2016","unstructured":"Rancic ZS. Commentary on \u2018contrast-induced nephropathy and long-term renal decline after percutaneous transluminal angioplasty for symptomatic peripheral arterial disease.\u2019. Eur J Vasc Endovasc Surg. 2016, 51:394. 10.1016\/j.ejvs.2015.12.013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann FJ","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, et al.. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019, 40:87-165. 10.1093\/eurheartj\/ehy394","journal-title":"Eur Heart J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2009.06.003","article-title":"Prevention of contrast-induced nephropathy: an overview","volume":"47","author":"Ellis JH","year":"2009","unstructured":"Ellis JH, Cohan RH. Prevention of contrast-induced nephropathy: an overview. Radiol Clin North Am. 2009, 47:801-11, v. 10.1016\/j.rcl.2009.06.003","journal-title":"Radiol Clin North Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.12.047","article-title":"Prevention of contrast-induced acute kidney injury after percutaneous coronary intervention for chronic total coronary occlusions","volume":"115","author":"Pavlidis AN","year":"2015","unstructured":"Pavlidis AN, Jones DA, Sirker A, Mathur A, Smith EJ. Prevention of contrast-induced acute kidney injury after percutaneous coronary intervention for chronic total coronary occlusions. Am J Cardiol. 2015, 115:844-51. 10.1016\/j.amjcard.2014.12.047","journal-title":"Am J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2013.05.09","article-title":"Statin treatment before percutaneous cononary intervention","volume":"5","author":"Leoncini M","year":"2013","unstructured":"Leoncini M, Toso A, Maioli M, Tropeano F, Bellandi F. Statin treatment before percutaneous cononary intervention. J Thorac Dis. 2013, 5:335-42. 10.3978\/j.issn.2072-1439.2013.05.09","journal-title":"J Thorac Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.05.011","article-title":"Statins and contrast-induced acute kidney injury with coronary angiography","volume":"127","author":"Gandhi S","year":"2014","unstructured":"Gandhi S, Mosleh W, Abdel-Qadir H, Farkouh ME. Statins and contrast-induced acute kidney injury with coronary angiography. Am J Med. 2014, 127:987-1000. 10.1016\/j.amjmed.2014.05.011","journal-title":"Am J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-011-9929-6","article-title":"Allopurinol, uric acid, and oxidative stress in cardiorenal disease","volume":"43","author":"Riegersperger M","year":"2011","unstructured":"Riegersperger M, Covic A, Goldsmith D. Allopurinol, uric acid, and oxidative stress in cardiorenal disease. Int Urol Nephrol. 2011, 43:441-9. 10.1007\/s11255-011-9929-6","journal-title":"Int Urol Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000034910.58454.fd","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang DH","year":"2002","unstructured":"Kang DH, Nakagawa T, Feng L, et al.. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002, 13:2888-97. 10.1097\/01.asn.0000034910.58454.fd","journal-title":"J Am Soc Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0542-z","article-title":"Potential role of allopurinol in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a randomized placebo-controlled trial","volume":"37","author":"Ghelich Khan Z","year":"2017","unstructured":"Ghelich Khan Z, Talasaz AH, Pourhosseini H, Hosseini K, Alemzadeh Ansari MJ, Jalali A. Potential role of allopurinol in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a randomized placebo-controlled trial. Clin Drug Investig. 2017, 37:853-60. 10.1007\/s40261-017-0542-z","journal-title":"Clin Drug Investig"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/9638.5255","article-title":"Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization","volume":"8","author":"Kumar A","year":"2014","unstructured":"Kumar A, Bhawani G, Kumari N, Murthy KS, Lalwani V, Raju ChN. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization. J Clin Diagn Res. 2014, 8:HC03-7. 10.7860\/JCDR\/2014\/9638.5255","journal-title":"J Clin Diagn Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.194397","article-title":"N-acetyl cysteine versus allopurinol in the prevention of contrast nephropathy in patients with chronic kidney disease: A randomized controlled trial","volume":"27","author":"Sadineni R","year":"2017","unstructured":"Sadineni R, Karthik KR, Swarnalatha G, Das U, Taduri G. N-acetyl cysteine versus allopurinol in the prevention of contrast nephropathy in patients with chronic kidney disease: A randomized controlled trial. Indian J Nephrol. 2017, 27:93-8. 10.4103\/0971-4065.194397","journal-title":"Indian J Nephrol"},{"key":"ref33","article-title":"Allopurinol prophylactic therapy and the prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A prospective randomized controlled trial","volume":"13","author":"Iranirad L","year":"2017","unstructured":"Iranirad L, Sadeghi MS, Bagheri A, et al.. Allopurinol prophylactic therapy and the prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A prospective randomized controlled trial. ARYA Atheroscler. 2017, 13:230-5.","journal-title":"ARYA Atheroscler"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.15171\/jarcm.2019.022","article-title":"Effect of allopurinol in the prevention of contrast-induced nephropathy in patients undergoing angioplasty: randomized clinical trial","volume":"7","author":"Bodagh H","year":"2019","unstructured":"Bodagh H, Esfahani Z, Aslanabadi N, et al.. Effect of allopurinol in the prevention of contrast-induced nephropathy in patients undergoing angioplasty: randomized clinical trial. J Anal Res Clin Med. 2019, 7:128-35. 10.15171\/jarcm.2019.022","journal-title":"J Anal Res Clin Med"},{"key":"ref35","article-title":"Effect of allopurinol versus saline hydration in preventing contrast-induced nephropathy","volume":"21","author":"Sultan K","year":"2023","unstructured":"Sultan K, Naeemullah, Afnan M, Shah U. Effect of allopurinol versus saline hydration in preventing contrast-induced nephropathy. NeuroQuantology. 2023, 21:809-21.","journal-title":"NeuroQuantology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015962","article-title":"Meta-analysis on allopurinol preventive intervention on contrast-induced acute kidney injury with random controlled trials: PRISMA","volume":"98","author":"Ma G","year":"2019","unstructured":"Ma G, Wang G, Xiao D, Teng W, Hui X, Ma G. Meta-analysis on allopurinol preventive intervention on contrast-induced acute kidney injury with random controlled trials: PRISMA. Medicine (Baltimore). 2019, 98:e15962. 10.1097\/MD.0000000000015962","journal-title":"Medicine (Baltimore)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5414\/CN109815","article-title":"Effects of allopurinol pretreatment on the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials","volume":"93","author":"Xin W","year":"2020","unstructured":"Xin W, Lin Z, Zhang T, Jia S. Effects of allopurinol pretreatment on the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials\u2029. Clin Nephrol. 2020, 93:24-33. 10.5414\/CN109815","journal-title":"Clin Nephrol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000663","article-title":"Allopurinol administration for the prevention of contrast-induced nephropathy: a network meta-analysis with trial sequential analysis","volume":"73","author":"Bellos I","year":"2019","unstructured":"Bellos I, Iliopoulos DC, Perrea DN. Allopurinol administration for the prevention of contrast-induced nephropathy: a network meta-analysis with trial sequential analysis. J Cardiovasc Pharmacol. 2019, 73:307-15. 10.1097\/FJC.0000000000000663","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/322170-evaluating-the-role-of-allopurinol-in-mitigating-contrast-induced-nephropathy-in-percutaneous-coronary-intervention-patients-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T16:27:29Z","timestamp":1735144049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/322170-evaluating-the-role-of-allopurinol-in-mitigating-contrast-induced-nephropathy-in-percutaneous-coronary-intervention-patients-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,25]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.76374","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,25]]}}}